Cornerstone Advisors (Washington)’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-957
| Closed | -$175K | – | 1359 |
|
|
2019
Q2 | $175K | Buy |
957
+14
| +1% | +$2.56K | 0.02% | 171 |
|
|
2019
Q1 | $173K | Buy |
943
+84
| +10% | +$15.4K | 0.02% | 159 |
|
|
2018
Q4 | $142K | Sell |
859
-1
| -0.1% | -$165 | 0.03% | 156 |
|
|
2018
Q3 | $166K | Sell |
860
-144
| -14% | -$27.8K | 0.11% | 148 |
|
|
2018
Q2 | $171K | Buy |
1,004
+20
| +2% | +$3.41K | 0.12% | 140 |
|
|
2018
Q1 | $160K | Hold |
984
| – | – | 0.11% | 139 |
|
|
2017
Q4 | $147K | Hold |
984
| – | – | 0.1% | 149 |
|
|
2017
Q3 | $150K | Buy |
984
+159
| +19% | +$24.2K | 0.1% | 149 |
|
|
2017
Q2 | $106K | Sell |
825
-159
| -16% | -$20.4K | 0.06% | 180 |
|
|
2017
Q1 | $108K | Hold |
984
| – | – | 0.06% | 180 |
|
|
2016
Q4 | $72K | Buy |
984
+243
| +33% | +$17.8K | 0.06% | 207 |
|
|
2016
Q3 | $65K | Buy |
741
+281
| +61% | +$24.6K | 0.05% | 219 |
|
|
2016
Q2 | $40K | Buy |
460
+12
| +3% | +$1.04K | 0.04% | 181 |
|
|
2016
Q1 | $36K | Buy |
448
+51
| +13% | +$4.1K | 0.04% | 198 |
|
|
2015
Q4 | $50K | Sell |
397
-82
| -17% | -$10.3K | 0.05% | 179 |
|
|
2015
Q3 | $50K | Hold |
479
| – | – | 0.04% | 175 |
|
|
2015
Q2 | $59K | Hold |
479
| – | – | 0.05% | 158 |
|
|
2015
Q1 | $57K | Buy |
479
+241
| +101% | +$28.7K | 0.04% | 176 |
|
|
2014
Q4 | $28K | Buy |
238
+9
| +4% | +$1.06K | 0.02% | 239 |
|
|
2014
Q3 | $26K | Sell |
229
-4
| -2% | -$454 | 0.02% | 116 |
|
|
2014
Q2 | $22K | Hold |
233
| – | – | 0.02% | 139 |
|
|
2014
Q1 | $16K | Buy |
233
+211
| +959% | +$14.5K | 0.02% | 155 |
|
|
2013
Q4 | $2K | Hold |
22
| – | – | ﹤0.01% | 265 |
|
|
2013
Q3 | $2K | Hold |
22
| – | – | ﹤0.01% | 243 |
|
|
2013
Q2 | $2K | Buy |
+22
| New | +$2K | ﹤0.01% | 202 |
|